is indicated in vulvar atrophy correction and symptoms related to it. Its inflitration in labia majora can bring volume, firmness, shape correction and considerable rejuvenation effect.1
NEAUVIA HA FILLERS ARE BASED ON A UNIQUE CROSS-LINKING TECHNOLOGY – SMART XROSS LINKING TECHNOLOGY – WHICH IS AN INNOVATIVE TECHNOLOGY TO COMBINE HYALURONIC ACID AND PEG POLYMERS IN ONE NETWORK.
PEG IS WIDELY USED TO CROSS-LINK POLYMERS, PARTICULARLY IN THE PHARMACEUTICAL AND BIOMATERIAL SECTORS, DUE TO ITS UNIQUENESS AND SAFETY PROFILE.2,3
This class III medical device is regulated under the EU MDD 93/42 Directive. Manufacturer: MATEX LAB SPA, via Carlo Urbani 2 ang. via Enrico Fermi, Brindisi, Italy.
Please carefully read the instructions in the leaflets. The use of this product require the intervention of a healthcare professional. Only to be used by physicians in accordance with local legislation, trained in the injection techniques on Hyaluronic Acid based fillers.
1. J. Biol Regul Homeost Agents. 2017 APR-JUN;31(2 Suppl. 2):153-161. A new hyaluronic acid polymer in the augmentation and restoration of labia majora. Zerbinati N1, Haddad RG2, Bader A3, Rauso R4, D’Este E5, Cipolla G5, Calligaro A6, Gonzalez P7, Salvatore S8, Serafin D9.
2. Marino et al., Immune profile of hyaluronic acid hydrogel polyethylene glycol crosslinked: An in vitro evaluation in human polymorphonuclear leukocyte, Dermatologic Therapy. April 2020, DOI: 10.1111/dth.13388.
3. In vitro toxicity assessment of crosslinking agents used in hyaluronic acid dermal filler Chang Hee Jeong et al, Toxicology In Vitro,2021 Feb;Volume70:105034., DOI: 10.1016/j.tiv.2020.105034.
Regulations and usage conditions for products vary from market to market and the content on this page is not intended for US or Canadian audiences. This website is designed for informational purpose only. This information is not intended as a substitute for informed medical advice or recommendations from healthcare professionals. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider.
Our Main Corporate office:
Tel : +971 4 435 7689
Fax : +971 4 435 7671
P.O.Box: 296397, Dubai-U.A.E.
E-mail: info@ls-aesthetics.com
This section is exclusively for medical representatives and clinic managers. By clicking 'Continue', you acknowledge that you are authorized to access this area.
Subscribe to the newsletter to receive the scientific and training updates from Lifestyle Aesthics Group
